Abstract
We performed a genome-wide association scan to search for sequence variants conferring risk of prostate cancer using 1,501 Icelandic men with prostate cancer and 11,290 controls. Follow-up studies involving three additional case-control groups replicated an association of two variants on chromosome 17 with the disease. These two variants, 33 Mb apart, fall within a region previously implicated by family-based linkage studies on prostate cancer. The risks conferred by these variants are moderate individually (allele odds ratio of about 1.20), but because they are common, their joint population attributable risk is substantial. One of the variants is in TCF2 (HNF1β), a gene known to be mutated in individuals with maturity-onset diabetes of the young type 5. Results from eight case-control groups, including one West African and one Chinese, demonstrate that this variant confers protection against type 2 diabetes.
Access options
Subscribe to Journal
Get full journal access for 1 year
70,80 €
only 5,90 € per issue
All prices include VAT for France.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
Amundadottir, L.T. et al. A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38, 652–658 (2006).
- 2.
Gudmundsson, J. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39, 631–637 (2007).
- 3.
Haiman, C.A. et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet. 39, 638–644 (2007).
- 4.
Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645–649 (2007).
- 5.
Roeder, K., Bacanu, S.A., Wasserman, L. & Devlin, B. Using linkage genome scans to improve power of association in genome scans. Am. J. Hum. Genet. 78, 243–252 (2006).
- 6.
Lange, E.M. et al. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 57, 326–334 (2003).
- 7.
Xu, J. et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am. J. Hum. Genet. 77, 219–229 (2005).
- 8.
Lange, E.M. et al. Fine-mapping the putative chromosome 17q21–22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis. Hum. Genet. 121, 49–55 (2007).
- 9.
Zuhlke, K.A. et al. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Clin. Cancer Res. 10, 5975–5980 (2004).
- 10.
Kraft, P. et al. Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet 1, e68 (2005).
- 11.
White, K.A., Lange, E.M., Ray, A.M., Wojno, K.J. & Cooney, K.A. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q. Prostate Cancer Prostatic Dis. 9, 298–302 (2006).
- 12.
Bellanne-Chantelot, C. et al. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 54, 3126–3132 (2005).
- 13.
Edghill, E.L., Bingham, C., Ellard, S. & Hattersley, A.T. Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J. Med. Genet. 43, 84–90 (2006).
- 14.
Kasper, J.S. & Giovannucci, E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15, 2056–2062 (2006).
- 15.
Winckler, W. et al. Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 56, 685–693 (2007).
- 16.
HillHarfe, K.L. et al. Fine mapping of chromosome 17 translocation breakpoints > or = 900 Kb upstream of SOX9 in acampomelic campomelic dysplasia and a mild, familial skeletal dysplasia. Am. J. Hum. Genet. 76, 663–671 (2005).
- 17.
Risch, N. Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 46, 222–228 (1990).
- 18.
Gulcher, J.R., Kristjansson, K., Gudbjartsson, H. & Stefansson, K. Protection of privacy by third-party encryption in genetic research in Iceland. Eur. J. Hum. Genet. 8, 739–742 (2000).
- 19.
Kutyavin, I.V. et al. A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res. 34, e128 (2006).
- 20.
Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131–138 (2003).
- 21.
Falk, C.T. & Rubinstein, P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51, 227–233 (1987).
- 22.
Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719–748 (1959).
- 23.
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
Acknowledgements
We thank the research subjects whose contribution made this work possible. We also thank the nurses at Noatun (deCODE's sample recruitment center) and personnel at the deCODE core facilities. This project was funded in part by contract number 018827 (Polygene) from the 6th Framework Program of the European Union and by US Department of Defense Congressionally Directed Medical Research Program W81XWH-05-1-0074. Support for the Africa America Diabetes Mellitus (AADM) study is provided by multiple institutes of the US National Institutes of Health: the National Center on Minority Health and Health Disparities (3T37TW00041-03S2), National Institute of Diabetes and Digestive and Kidney (DK072128), the National Human Genome Research Institute and the National Center for Research Resources (RR03048). The Scottish Diabetes case control study was funded by the Wellcome Trust. C.N.A.P. and A.M. are supported by the Scottish Executive Generation Scotland Initiative. The Hong Kong Diabetes case control study was supported by the Hong Kong Research Grants Committee Central Allocation Scheme CUHK 1/04C.
Author information
Author notes
- Julius Gudmundsson
- & Patrick Sulem
These authors contributed equally to this work.
Affiliations
deCODE genetics, Sturlugata 8, 101 Reykjavik, Iceland.
- Julius Gudmundsson
- , Patrick Sulem
- , Valgerdur Steinthorsdottir
- , Jon T Bergthorsson
- , Gudmar Thorleifsson
- , Andrei Manolescu
- , Thorunn Rafnar
- , Daniel Gudbjartsson
- , Adam Baker
- , Asgeir Sigurdsson
- , Margret Jakobsdottir
- , Thorarinn Blondal
- , Simon N Stacey
- , Agnar Helgason
- , Steinunn Gunnarsdottir
- , Adalheidur Olafsdottir
- , Kari T Kristinsson
- , Birgitta Birgisdottir
- , Shyamali Ghosh
- , Steinunn Thorlacius
- , Dana Magnusdottir
- , Gerdur Stefansdottir
- , Kristleifur Kristjansson
- , Michael L Frigge
- , Jeffrey R Gulcher
- , Unnur Thorsteinsdottir
- , Augustine Kong
- & Kari Stefansson
Department of Pathology, Landspitali-University Hospital, 101 Reykjavik, Iceland.
- Bjarni A Agnarsson
- , Kristrun R Benediktsdottir
- & Rosa B Barkardottir
Center for Clinical and Basic Research A/S, DK-2750 Ballerup, Denmark.
- Yu Bagger
- & Claus Christiansen
University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
- Robert L Wilensky
- , Muredach P Reilly
- & Daniel J Rader
Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland.
- Andrew D Morris
Population Pharmacogenetics Group, Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland.
- Charlotte H Kimber
- & Colin N A Palmer
National Human Genome Center, Howard University, Department of Community and Family Medicine, Washington, DC 20060, USA.
- Adebowale Adeyemo
- , Yuanxiu Chen
- , Jie Zhou
- & Charles Rotimi
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong.
- Wing-Yee So
- , Peter C Y Tong
- , Maggie C Y Ng
- & Juliana C N Chan
Steno Diabetes Center, DK-2820 Copenhagen, Denmark.
- Torben Hansen
- , Gitte Andersen
- , Knut Borch-Johnsen
- & Oluf Pedersen
Faculty of Health Science, University of Aarhus, DK-8000 Aarhus, Denmark.
- Knut Borch-Johnsen
- & Oluf Pedersen
Research Centre for Prevention and Health, Glostrup University Hospital, DK-2600 Glostrup, Denmark.
- Knut Borch-Johnsen
- & Torben Jorgensen
Division of Medical Oncology, Lozano Blesa University Hospital, University of Zaragoza, 50009 Zaragoza, Spain.
- Alejandro Tres
- , Manuel Ruiz-Echarri
- & Jose I Mayordomo
The Institute of Health Sciences, Nanotechnology Institute of Aragon, 50009 Zaragoza, Spain.
- Alejandro Tres
- , Laura Asin
- , Berta Saez
- & Jose I Mayordomo
Division of Radiation Oncology, Lozano Blesa University Hospital, University of Zaragoza, 50009 Zaragoza, Spain.
- Fernando Fuertes
Department of Urology, Maas Ziekenhuis, 5830 AB Boxmeer, The Netherlands.
- Erica van Boven
Department of Clinical Chemistry, Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.
- Siem Klaver
- & Dorine W Swinkels
Comprehensive Cancer Center East, 6501 BG Nijmegen, and Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.
- Katja K Aben
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.
- Theresa Graif
- , John Cashy
- & William J Catalona
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
- Brian K Suarez
Department of Urology, Gelderse Vallei Hospital, 6716 RP Ede, The Netherlands.
- Onco van Vierssen Trip
Department of Human Genetics, University of Chicago, Chicago, Illinois 60637, USA.
- Carole Ober
Department of Pathology and Laboratory Medicine, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
- Marten H Hofker
Department of Molecular Genetics, Maastricht University, 6200 MD Maastricht, The Netherlands.
- Marten H Hofker
Department of Genetics, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
- Cisca Wijmenga
Complex Genetics Section, Department of Biomedical Genetics, University Medical Centre Utrecht, 3508 AB Utrecht, The Netherlands.
- Cisca Wijmenga
Landspitali-University Hospital, 101 Reykjavik, Iceland.
- Gunnar Sigurdsson
- & Rafn Benediktsson
Icelandic Heart Association, 201 Kopavogur, Iceland.
- Gunnar Sigurdsson
- & Rafn Benediktsson
Department of Urology, Landspitali-University Hospital, 101 Reykjavik, Iceland.
- Eirikur Jonsson
- & Gudmundur V Einarsson
Department of Epidemiology and Biostatistics and Department of Urology, Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.
- Lambertus A Kiemeney
Authors
Search for Julius Gudmundsson in:
Search for Patrick Sulem in:
Search for Valgerdur Steinthorsdottir in:
Search for Jon T Bergthorsson in:
Search for Gudmar Thorleifsson in:
Search for Andrei Manolescu in:
Search for Thorunn Rafnar in:
Search for Daniel Gudbjartsson in:
Search for Bjarni A Agnarsson in:
Search for Adam Baker in:
Search for Asgeir Sigurdsson in:
Search for Kristrun R Benediktsdottir in:
Search for Margret Jakobsdottir in:
Search for Thorarinn Blondal in:
Search for Simon N Stacey in:
Search for Agnar Helgason in:
Search for Steinunn Gunnarsdottir in:
Search for Adalheidur Olafsdottir in:
Search for Kari T Kristinsson in:
Search for Birgitta Birgisdottir in:
Search for Shyamali Ghosh in:
Search for Steinunn Thorlacius in:
Search for Dana Magnusdottir in:
Search for Gerdur Stefansdottir in:
Search for Kristleifur Kristjansson in:
Search for Yu Bagger in:
Search for Robert L Wilensky in:
Search for Muredach P Reilly in:
Search for Andrew D Morris in:
Search for Charlotte H Kimber in:
Search for Adebowale Adeyemo in:
Search for Yuanxiu Chen in:
Search for Jie Zhou in:
Search for Wing-Yee So in:
Search for Peter C Y Tong in:
Search for Maggie C Y Ng in:
Search for Torben Hansen in:
Search for Gitte Andersen in:
Search for Knut Borch-Johnsen in:
Search for Torben Jorgensen in:
Search for Alejandro Tres in:
Search for Fernando Fuertes in:
Search for Manuel Ruiz-Echarri in:
Search for Laura Asin in:
Search for Berta Saez in:
Search for Erica van Boven in:
Search for Siem Klaver in:
Search for Dorine W Swinkels in:
Search for Katja K Aben in:
Search for Theresa Graif in:
Search for John Cashy in:
Search for Brian K Suarez in:
Search for Onco van Vierssen Trip in:
Search for Michael L Frigge in:
Search for Carole Ober in:
Search for Marten H Hofker in:
Search for Cisca Wijmenga in:
Search for Claus Christiansen in:
Search for Daniel J Rader in:
Search for Colin N A Palmer in:
Search for Charles Rotimi in:
Search for Juliana C N Chan in:
Search for Oluf Pedersen in:
Search for Gunnar Sigurdsson in:
Search for Rafn Benediktsson in:
Search for Eirikur Jonsson in:
Search for Gudmundur V Einarsson in:
Search for Jose I Mayordomo in:
Search for William J Catalona in:
Search for Lambertus A Kiemeney in:
Search for Rosa B Barkardottir in:
Search for Jeffrey R Gulcher in:
Search for Unnur Thorsteinsdottir in:
Search for Augustine Kong in:
Search for Kari Stefansson in:
Competing interests
J.G., P.S., V.S., J.T.B., G.T., A.M., T.R., D.G., A.B., A.S., M.J., T.B., S.N.S., A.H., S. Gunnarsdottir, A.O., K.T.K., B.B., S. Ghosh, S.T., D.M., G.S., K.K., M.L.F., J.R.G., U.T., A.K. and K.S. are shareholders in deCODE genetics, Inc.
Corresponding authors
Correspondence to Julius Gudmundsson or Kari Stefansson.
Supplementary information
PDF files
- 1.
Supplementary Text and Figures
Methods, Note, Tables 1–3 and Fig 1
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.
About this article
Further reading
-
1.
The molecular biology of prostate cancer: current understanding and clinical implications
Prostate Cancer and Prostatic Diseases (2018)
-
2.
BMC Medical Genetics (2018)
-
3.
Biochemical Genetics (2018)
-
4.
Strahlentherapie und Onkologie (2018)
-
5.
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Nature Genetics (2018)